G. Granger

R. Burger, P. Disaia, M. V. van Eden, 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Immunotherapy of ovarian cancer. II. In vitro generation and characterization of lymphokine‐activated killer T cells from the peripheral blood of recurrent ovarian cancer patients

F. Cappuccini, J. Lucci, R. Yamamoto, 1992, Gynecologic oncology.

Identification of tumor necrosis factor and lymphotoxin blocking factor(s) in the ascites of patients with advanced and recurrent ovarian cancer.

P. Disaia, T. Gatanaga, F. Cappuccini, 1991, Lymphokine and cytokine research.

The human LT system. II. Immunological relationships of LT molecules released by mitogen activated human lymphocytes in vitro.

R. Yamamoto, G. Granger, J. Lewis, 1978, Cellular immunology.

Inhibition of the lytic phase of murine t-cell-mediated alloimmune cytotoxicity by a rat antiactivated t-cell antiserum.

C. Ware, G. Granger, P. Duffey, 1981, Cellular immunology.

The human LT system: VII. Release of soluble forms and delivery to target L-929 cells by lectin-preactivated human lymphocytes in the absence of protein synthesis and secretory processes☆

G. Granger, S. Ford, J. Hiserodt, 1978 .

Development and characterization of an interleukin-2-transduced human ovarian carcinoma vaccine not expressing major histocompatibility complex molecules tumor

G. Granger, A. Santin, S. Pecorelli, 2004 .

Development and characterization of an interleukin‐2‐transduced human ovarian carcinoma tumor vaccine not expressing major histocompatibility complex molecules

P. Disaia, G. Granger, G. Ioli, 1996, American journal of obstetrics and gynecology.

The human LT system. XI. Identification of LT and "TNF-like" forms from stimulated natural killers, specific and nonspecific cytotoxic human T cells in vitro.

C. Ware, R. Yamamoto, G. Granger, 1986, Journal of immunology.

Cytotoxic and Growth Inhibitory Lymphokines

C. Ware, G. Granger, J. Hiserodt, 1979 .

Lymphocyte in vitro cytotoxicity: mechanism of lymphotoxin-induced target cell destruction.

G. Granger, T. Williams, 1969, Journal of immunology.

Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.

B. Bonavida, G. Granger, S. C. Wright, 1983, Journal of immunology.

Production of lymphotoxin by isolated human tonsillar B lymphocytes and B lymphocyte cell lines.

J. Walters, E. Jeffes, G. Granger, 1989, The Journal of clinical investigation.

Lymphocyte effector molecules and cell-mediated immune reactions.

A. Prieur, R. Daynes, E. Jeffes, 1975, Contemporary topics in molecular immunology.

Lymphotoxins: Mediators of Cellular Activation, Inflammation, and Cell Lysis That Are Immunologically Related to Macrophage Toxins and Tumor Necrosis Factors

R. Yamamoto, G. Granger, B. Averbook, 1988 .

The effect of vitamin D3 on the production of cytotoxic factors by human peripheral blood mononuclear cells.

J. Ocariz, N. Vaziri, G. Granger, 1989, Cancer research.

The in vitro induction and release of a cell toxin by immune C57B1-6 mouse peritoneal macrophages.

G. Granger, J. Kramer, 1972, Cellular immunology.

Human lymphotoxin: purification and some properties.

G. Granger, W. Kolb, E. C. Laserna, 1973, Proceedings of the National Academy of Sciences of the United States of America.

The paradoxical effects of somatostatin on the bioactivity and production of cytotoxins derived from human peripheral blood mononuclear cells.

J. Ocariz, N. Vaziri, R. Yamamoto, 1991, British Journal of Cancer.

Lymphocyte in vitro cytotoxicity: mechanism of human lymphotoxin-induced target cell destruction.

G. Granger, T. Williams, G. A. Granger, 1973, Cellular immunology.

Homograft Target Cells: Specific Destruction in vitro by Contact Interaction with Immune Macrophages

G. Granger, R. S. Weiser, 1964, Science.

Mechanism of human lymphotoxin and tumor necrosis factor induced destruction of cells in vitro: Phospholipase activation and deacylation of specific‐membrane phospholipids

K. Longmuir, R. Yamamoto, G. Granger, 1990, Journal of cellular physiology.

Growth of the endometrial adenocarcinoma cell line AN3 CA is modulated by tumor necrosis factor and its receptor is up-regulated by estrogen in vitro.

T. Gatanaga, F. Cappuccini, R. Yamamoto, 1992, Endocrinology.

PRELIMINARY HUMAN LYMPHOTOXINS: PURIFICATION TO ELECTROPHORETIC HOMOGENEITY OF THE UH RECEPTOR-BEARING CLASS

G. Granger, 2002 .

Heterogeneity of soluble suppressor factors in rat malignant ascites.

G. Granger, A. Wile, M. Contino, 1988, Oncology.

Isolation and initial characterization of tumoricidal monokine(s) from the human monocytic leukemia cell line THP-1.

G. Granger, J. Klostergaard, C. Armstrong, 1985, Journal of the National Cancer Institute.

Isolation and identification of an alpha 2 subclass lymphotoxin (LT) subunit from the high-molecular-weight (complex) human LT class.

G. Granger, J. Devlin, J. Klostergaard, 1984, Cellular immunology.

Lymphotoxins, a Multicomponent Family of Effector Molecules

R. Yamamoto, G. Granger, S. Orr, 1984 .

Purification to electrophoretic homogeneity of human alpha lymphotoxin from a cloned continuous lymphoblastoid cell line IR 3.4.

R. Yamamoto, G. Granger, D. Johnson, 1983, Molecular immunology.

Purification of human alpha-light class lymphotoxin to electrophoretic homogeneity.

G. Granger, J. Klostergaard, S. Long, 1981, Molecular immunology.

Human lymphotoxins: Purification to electrophoretic homogeneity of the αH receptor-bearing class

G. Granger, J. Klostergard, 1981 .

Human lymphotoxins: purification to electrophoretic homogeneity of the alpha H receptor-bearing class.

G. Granger, J. Klostergaard, 1981, Molecular immunology.

Human and murine lymphotoxins as a multicomponent system: progress in purification of the human alpha L component.

R. Yamamoto, G. Granger, J. Klostergaard, 1980, Molecular immunology.

The LT system in experimental animals. III. Physicochemical characteristics and relationships of lymphotoxin (LT) molecules released in vitro by activated lymphoid cells from several animal species.

G. Granger, P. Horn, J. Hiserodt, 1979, Journal of immunology.

The LT system in experimental animals. II. Physical and immunologic characteristics of molecules with LT activity rapidly released by murine lymphoid cells activated on lectin-coated allogeneic monolayers in vitro.

G. Granger, J. Hiserodt, G. J. Tiangco, 1979, Journal of immunology.

Release of LT molecules with restricted physical heterogeneity by a continuous human lymphoid cell line in vitro.

E. Jeffes, G. Granger, D. Fair, 1979, Molecular immunology.

Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble receptors in vitro.

T. Gatanaga, R. Yamamoto, G. Granger, 1993, The Journal of surgical research.

Macrophage Colony-Stimulating Factor Membrane-Associated Isoform of Genetically Engineered to Express the Glioblastoma Multiforme Using Tumor Cells Development of Systemic Immunity to Wepsic and

G. Granger, M. Graf, M. Jadus, 1999 .

Lymphocyte in vitro Cytotoxicity: Specific Release of Lymphotoxin-like Materials from Tuberculin-sensitive Lymphoid Cells

G. Granger, T. Williams, S. Shacks, 1969, Nature.

Lymphocyte in vitro cytotoxicity: characterization of mouse lymphotoxin.

G. Granger, W. Kolb, 1970, Cellular immunology.

Title Generation of stimulated , lymphokine activated T killer ( T-LAK ) cells from the peripheral blood of normal donors and adult patients with recurrent glioblastoma

E. Jeffes, R. Yamamoto, G. Granger, 2002 .

Identification of the proteolytic enzyme which cleaves human p75 TNF receptor in vitro.

K. Takishima, T. Gatanaga, G. Granger, 1996, Biochemical and biophysical research communications.

Molecular cloning and expression of a receptor for human tumor necrosis factor

G. Wong, D. Goeddel, W. Kohr, 1990, Cell.

Mechanism of release of soluble forms of tumor necrosis factor/lymphotoxin receptors by phorbol myristate acetate-stimulated human THP-1 cells in vitro.

T. Gatanaga, C. Hwang, G. Granger, 1993, Journal of immunology.

Lymphotoxin detected in the blister fluid of bullous pemphigoid patients

E. Jeffes, R. Yamamoto, G. Granger, 2004, Journal of Clinical Immunology.

Lymphocyte in vitro cytotoxicity: correlation of derepression with release of lymphotoxin from human lymphocytes.

G. Granger, T. Williams, 1969, Journal of immunology.

Lymphocyte in vitro Cytotoxicity: Lymphotoxins of Several Mammalian Species

G. Granger, T. Williams, 1968, Nature.

Lymphocyte in vitro cytotoxicity: mechanisms of immune and non-immune small lymphocyte mediated target L cell destruction.

G. Granger, G A Granger, W P Kolb, 1968, Journal of immunology.

Immunotherapy with transfer factor in disseminated coccidioidal osteomyelitis and arthritis.

G. Granger, H. Novey, L. Thrupp, 1974, The Western journal of medicine.

Efficient, inefficient, and abortive infection of different mammalian cells by small RNA viruses.

J. Holland, G. Granger, C. Buck, 1967, Virology.

Relationship between cutaneous delayed hypersensitivity and cell-mediated immunity in vitro responses assessed by diphtheria and tetanus toxoids.

G. Granger, S. Galant, C. E. Groncy, 1977, The Journal of allergy and clinical immunology.

Cell-mediated immunity in vitro: a highly sensitive assay for human lymphotoxin.

R. Daynes, G. Granger, B. Spofford, 1974, Journal of immunology.

Characterization of a natural agglutinin present in the hemolymph of the California sea hare, Aplysia californica.

G. Granger, G. B. Pauley, S. Krassner, 1971, Journal of invertebrate pathology.

The role of lymphotoxin in target cell destruction by mitogen-activated human lymphocytes. I. The correlation of target cell sensitivity to lymphotoxin and the intact lymphocyte.

G. Granger, S. Kramer, G. A. Granger, 1975, Cellular immunology.

Mechanisms of lymphocyte-mediated cytotoxicity. I. The effects of anti-human lymphotoxin antisera on the cytolysis of allogeneic B cell lines by MLC-sensitized human lymphocytes in vitro.

C. Ware, G. Granger, 1981, Journal of immunology.

The human LT system. VIII. A target cell-dependent enzymatic activation step required for the expression of the cytotoxic activity of human lymphotoxin.

G. Granger, M. Weitzen, 1980, Journal of immunology.

Inhibition of human NK-induced cell lysis and soluble cell-lytic molecules with anti-human LT antisera and various saccharides.

R. Yamamoto, G. Granger, E. Innins, 1983, Cellular immunology.

The LT system in experimental animals. I. Rapid release of high levels of lymphotoxin (LT) activity from murine lymphocytes during the interaction with lectin-treated allogeneic or xenogeneic target cells in vitro.

G. Granger, J. Hiserodt, G. J. Tiangco, 1979, Journal of immunology.

Therapy of recurrent high grade gliomas with surgery, and autologous mitogen activated IL-2 stimulated killer (MAK) Lymphocytes: I. Enhancement of MAK lytic activity and cytokine production by PHA and clinical use of PHA

E. Jeffes, R. Yamamoto, G. Granger, 1993, Journal of Neuro-Oncology.

The human lymphotoxin system--VI. Identification of various saccharides on LT molecules and their contribution to cytotoxicity and charge heterogeneity.

G. Granger, M. Tóth, G. A. Granger, 1979, Molecular immunology.

The role of the LT system in cell destruction in vitro

R. Yamamoto, G. Granger, M. Ross, 1981 .

Antibodies against human lymphokines: I. Methods for induction of antibodies capable of neutralizing stable (alpha) and unstable (beta) lymphotoxins released in vitro by activated human lymphocytes.

R. Yamamoto, G. Granger, J. Lewis, 1977, Journal of immunological methods.

Lymphocyte Cytotoxicity in vitro: Activation and Release of a Cytotoxic Factor

G. Granger, T. Williams, 1968, Nature.

Immunology and Developmental Psychopathology

G. Granger, D. Granger, S. Granger, 2015 .

Lymphotoxins - a multicomponent system of growth inhibitory and cell-lytic glycoproteins.

R. Yamamoto, G. Granger, J. Devlin, 1984, Advances in experimental medicine and biology.

Recombinant human alpha lymphotoxin (tumor necrosis factor-beta) induces peripheral neutrophilia and lymphopenia in the rat.

T. Ulich, G. Granger, J. Del Castillo, 1987, The American journal of pathology.

PURIFICATION OF THE ALPHA-HEAVY CLASS OF HUMAN LYMPHOTOXIN TO ELECTROPHORETIC HOMOGENEITY

G. Granger, J. Klostergaard, S. Orr, 1982 .

Relationship of lymphotoxin secretion and DNA synthesis in the human mixed lymphocytes reaction in vitro.

G. Granger, J. Kramer, 1975, Cellular immunology.

Mechanisms of lymphocyte-induced cell and tissue destruction in vitro.

G. Granger, 1970, The American journal of pathology.

THE IDENTIFICATION OF TWO NEW CLASSES OF LYMPHOTOXIN RELEASED BY LECTIN ACTIVATED HUMAN T LYMPHOCYTES THAT POSSESS IG-LIKE RECEPTORS

R. Yamamoto, G. Granger, J. Klostergaard, 1982 .

Development of systemic immunity to glioblastoma multiforme using tumor cells genetically engineered to express the membrane-associated isoform of macrophage colony-stimulating factor.

G. Granger, M. Graf, M. Jadus, 1997, Journal of immunology.

Cytochrome P-450 from bovine adrenocortical mitochondria. Immunochemical properties and purity.

G. Granger, P. Hall, M. Watanuki, 1978, The Journal of biological chemistry.

Initiation and completion of mitosis in HeLa cells in the absence of protein synthesis.

J. Holland, G. Granger, C. Buck, 1967, Currents in modern biology.

Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound−guided fine‐needle injection in patients with advanced pancreatic carcinoma

Kenneth J. Chang, G. Granger, P. Nguyen, 2000, Cancer.

Studies of membrane-associated and soluble (secreted) lymphotoxin in human lymphokine-activated T-killer cells in vitro.

T. Gatanaga, G. Granger, A. Horiuchi, 1992, Lymphokine and cytokine research.

The LT system in experimental animals. IV. Rapid specific lysis of 51CR-labeled allogeneic target cells by highly unstable high m.w. lymphotoxin-receptor complex(es) released in vitro by activated alloimmune murine T lymphocytes.

G. Granger, J. Hiserodt, G. J. Tiangco, 1979, Journal of immunology.

The regulation of TNF receptor mRNA synthesis, membrane expression, and release by PMA- and LPS-stimulated human monocytic THP-1 cells in vitro.

T. Gatanaga, C. Hwang, F. Cappuccini, 1991, Cellular immunology.

MECHANISMS OF LYMPHOCYTE-MEDIATED CYTOTOXICITY

G. Granger, Carl, Ware, 2001 .

Identification of human lymphocyte-derived lymphotoxins with binding and cell-lytic activity on NK-sensitive cell lines in vitro.

R. Yamamoto, G. Granger, M. Weitzen, 1983, Cellular immunology.

LYMPHOTOXINS: AN NK-LIKE LT SYSTEM

R. Yamamoto, G. Granger, J. Devlin, 1982 .

Stabilization and functional studies of high-molecular-weight murine lymphotoxins.

R. Yamamoto, G. Granger, J. Devlin, 1981, Cellular immunology.

Mechanisms of lymphocyte-mediated cytotoxicity. II. biochemical and serologic identification of a precursor lymphotoxin form (pre-LT) produced by MLC-sensitized human T lymphocytes in vitro.

C. Ware, G. Granger, P. C. Harris, 1981, Journal of immunology.

Intra-arterial administration of TNF-α followed by arterial ablation is an effective therapy for a regionally confined TNF-resistant rat mammary adenocarcinoma

E. Jeffes, R. Yamamoto, G. Granger, 2002, Cancer Immunology, Immunotherapy.

Regulation of growth of human diploid fibrobalasts by factors elaborated by activated lymphoid cells

P. Rabinovitch, R. Page, G. Granger, 1982, Journal of cellular physiology.

The human LT system. V. A comparison of the relative lytic effectiveness of various MW human LT classes on 51Cr-labeled allogeneic target cells in vitro: enhanced lysis by LT complexes associated with Ig-like receptor(s).

R. Yamamoto, G. Granger, J. Hiserodt, 1979, Cellular immunology.

The role of lymphotoxin in target cell destruction induced by mitogen-activated human lymphocytes in vitro. II. The correlation of temperature and trypsin-sensitive phases of lymphotoxin-induced and lymphocyte-mediated cytotoxicity.

G. Granger, S. Kramer, 1976, Journal of immunology.

An improved in vitro assay for lymphotoxin.

G. Granger, J. Kramer, 1972, Cellular immunology.

Inhibition of human lectin-dependent cell-mediated cytotoxicity, natural killer-like cytotoxicity, and cytotoxic T-lymphocyte-mediated cytolysis by xenoantisera raised against concanavalin A-stimulated human lymphocytes.

G. Granger, J. Devlin, J. D. Phaneuf, 1982, Cellular immunology.

THE PATHOGENESIS OF ACUTE ALLOGENEIC DISEASE IN MICE STUDIED BY PARABIOSIS

G. Granger, R. S. Weiser, B. Holmes, 1965, Transplantation.

PRODUCTION OF ACUTE ALLOGENEIC DISEASE IN MICE

P. Baker, G. Granger, J. Jutila, 1965, Transplantation.

Homograft Target Cells: Contact Destruction in vitro by Immune Macrophages

G. Granger, R. S. Weiser, 1966, Science.

THE LT SYSTEM IN EXPERIMENT AL ANIMALS IV. Rapid Specific Lysis of 51 CR-Labeled Allogeneic Target Cells by Highly Unstable High M.W. Lymphotoxin-Receptor Complex(es) Released in Vitro by Activated Alloimmune Murine T Lymphocytes 1

G. Granger, J. Hiserodt, G. J. Tiangco, 2006 .

RAPID SPECIFIC LYSIS OF CR-51-LABELED ALLOGENEIC TARGET-CELLS BY HIGHLY UNSTABLE HIGH MW LYMPHOTOXIN-RECEPTOR COMPLEX ( ES ) RELEASED INVITRO BY ACTIVATED ALLOIMMUNE MURINE LYMPHOCYTES-T Permalink

G. Granger, J. Hiserodt, G. J. Tiangco, 2006 .

Mechanisms of lymphocyte-mediated cytotoxicity. III. Characterization of the mechanism of inhibition of the human alloimmune lymphocyte-mediated cytotoxic reaction by polyspecific anti-lymphotoxin sera in vitro.

C. Ware, G. Granger, G. A. Granger, 1981, Journal of immunology.

Rat Mitogen‐Stimulated Lymphokine‐Activated T Killer Cells: Production and Effects on C6 Glioma Cells In Vitro and In Vivo in the Brain of Wistar Rats

J. Lucci, E. Jeffes, R. Yamamoto, 1991, Journal of immunotherapy : official journal of the Society for Biological Therapy.

Chromatographic alterations in transfer RNA's accompanying speciation, differentiation and tumor formation.

J. Holland, G. Granger, C. Buck, 1968, Journal of molecular biology.

J. Holland, G. Granger, C. Buck, 1967, Proceedings of the National Academy of Sciences of the United States of America.

Homograft target cells: contact destruction in vitro by immune macrophages.

G. Granger, R. S. Weiser, 1966, Science.

Binding of human lymphotoxin to target-cell membranes and its relation to cell-mediated cytodestruction.

R. Daynes, G. Granger, D. Hessinger, 1973, Proceedings of the National Academy of Sciences of the United States of America.

The human LT system. I. Physical-chemical heterogeneity of LT molecules released by mitogen activated human lymphocytes in vitro.

R. Yamamoto, G. Granger, J. Hiserodt, 1978, Cellular immunology.

Inducible macrophage cytotoxins. I. Biokinetics of activation and release in vitro.

G. Granger, J. Klostergaard, T. Reidarson, 1982, Journal of the National Cancer Institute.

Studies on in vitro models of cellular immunity: the role of T and B cells in the secretion of lymphotoxin.

G. Granger, J. Chiller, S. Shacks, 1973, Cellular immunology.

HUMAN AND MURINE LYMPHOTOXINS AS A MULTICOMPONENT SYSTEM: PROGRESS IN PURrFICATION OF THE HUMAN ~1~ COMPONENT

R. Yamamoto, G. Granger, J. Klostergaard, 2002 .

ROLE OF LYMPHOTOXINS IN NATURAL CYTOTOXICITY

R. Yamamoto, G. Granger, J. Devlin, 1982 .

The human LT system. IV. Studies on the large MW LT complex class: association of these molecules with specific antigen binding receptor(s) in vitro.

R. Yamamoto, G. Granger, J. Hiserodt, 1978, Cellular immunology.

Identification of membrane-associated lymphotoxin (LT) on mitogen-activated human lymphocytes using heterologous anti-LT antisera in vitro.

C. Ware, G. Granger, J. Hiserodt, 1977, Cellular immunology.

Inhibition of human lymphocyte-mediated mitogen-induced cytotoxicity of murine L-929 cells by heterologous anti-human lymphotoxin antisera in vitro.

G. Granger, J. Hiserodt, 1977, Journal of immunology.

Identification of multiple cytolytic components associated with the beta-LT class of lymphotoxins released by mitogen-activity human lymphocytes in vitro.

G. Granger, J. Hiserodt, D. Fair, 1976, Journal of immunology.

In vitro lymphocyte cytotoxicity. II. Unstable lymphotoxins (beta-LT) secreted and inactivated by mitogen-stimulated human lymphocytes.

G. Granger, J. Hiserodt, 1976, Cellular immunology.

Lymphocyte effector molecules: an vitro production method for obtaining liter volumes of supernatants from mitogen-stimulated human lymphocytes.

R. Lundak, R. Yamamoto, G. Granger, 1976, Journal of immunological methods.

In vitro lymphocyte cytotoxicity. I. Evidence of multiple cytotoxic molecules secreted by mitogen activated human lymphoid cells in vitro.

A. Prieur, G. Granger, J. Hiserodt, 1976, Cellular immunology.

Relationship of cloning inhibition factor, "lymphotoxin" factor, and proliferation inhibition factor release in vitro by mitogen-activated human lymphoctes.

E. Jeffes, G. Granger, 1975, Journal of immunology.

Lymphocyte in vitro cytotoxicity: characterization of human lymphotoxin.

G. Granger, W. Kolb, 1968, Proceedings of the National Academy of Sciences of the United States of America.

14 – LYMPHOCYTE ACTIVATION AND LYMPHOTOXIN PRODUCTION

G. Granger, T. Williams, W. Kolb, 1971 .

Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy

B. Monk, R. Burger, P. Disaia, 2004, Cancer.

Production of macrophage migration inhibitory factor and lymphotoxin by leukocytes from normal and Wiskott-Aldrich syndrome patients.

G. Granger, R. Blaese, J. Oppenheim, 1973, Cellular immunology.

Relationship of CIF, LT, and PIF released in vitro by activated human lymphocytes. II. A further functional comparison of LT and PIF activities on HeLa and L-929 target cells.

E. Jeffes, G. Granger, 1976, Journal of immunology.

Trauma causes sustained elevation of soluble tumor necrosis factor receptors.

G. Granger, K. Waxman, M. Cinat, 1994, Journal of the American College of Surgeons.

Soluble suppressor factors elaborated in experimental malignant ascites.

M. Nahabedian, G. Granger, A. Wile, 1984, Cellular immunology.

Tumor necrosis factor : structure, mechanism of action, role in disease and therapy

B. Bonavida, G. Granger, Related Cytokines, 1990 .

Lymphocyte Effector Molecules: Mechanism of Human-Lymphotoxin Induced in Vitro Target Cell Destruction and Role in PHA-Induced Lymphocyte-Target Cell Cytolysis

G. Granger, T. Williams, 1971 .

The human LT system. III. Characterization of a high molecular weight LT class (complex) composed of the various smaller MW LT classes and subclasses in association with Ig-like molecules.

R. Yamamoto, G. Granger, J. Hiserodt, 1978, Cellular immunology.

12 – Lymphotoxins: A Multicomponent Family of Cell-Lytic and Growth-Inhibitory Proteins

R. Yamamoto, G. Granger, S. Orr, 1985 .

RECEPTOR AND NON-RECEPTOR ASSOCIATED, LYMPHOCYTE-DERIVED CELL-LYTIC MOLECULES1

R. Yamamoto, G. Granger, J. Klostergaard, 1981 .

The regulation of lymphotoxin release from stimulated human lymphocyte cultures: the requirement for continual mitogen stimulation.

R. Daynes, G. Granger, 1974, Cellular immunology.

Anaphylatoxin formation by contact activation of plasma. I. Activation by zymosan without participation of antibody

G. Granger, V. Brade, W. Vogt, 1971, European journal of immunology.

KINETICS AND MECHANISMS OF RECOMBINANT HUMAN INTERLEUKIN 1 AND NEUTROPHILS AND LYMPHOCYTES1 TUMOR NECROSIS FACTOR-a-INDUCED CHANGES IN CIRCULATING NUMBERS OF

Del, R. Thomas, G. Granger, 2001 .

Mechanism of human lymphotoxin and tumor necrosis factor induced destruction of cells in vitro: Phospholipase activation and deacylation of specific‐membrane phospholipids

K. Longmuir, R. Yamamoto, G. Granger, 1990, Journal of cellular physiology.

Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro.

R. Burger, Y. Abe, T. Gatanaga, 1993, Journal of immunology.

Lymphocyte in vitro cytotoxicity: characterization of mouse lymphotoxin.

G. Granger, W. Kolb, 1970, Cellular immunology.

A physicochemical and immunologic comparison of the cell growth inhibitory activity of human lymphotoxins and interferons in vitro.

C. Ware, G. Granger, 1979, Journal of immunology.

In vitro cytotoxicity of human recombinant tumor necrosis factor alpha in association with radiotherapy in a human ovarian carcinoma cell line.

P. Disaia, J. Lucci, G. Granger, 1990, Gynecologic oncology.